- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bonesupport Holding AB (BONEX)
Bonesupport Holding AB stock price live, this page displays ST BONEX stock exchange data. View the BONEX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bonesupport Holding AB real time stock price chart below.
What Is the Bonesupport Holding AB Stock Price Today?
The Bonesupport Holding AB stock price today is 187.50.
What Is the Stock Symbol for Bonesupport Holding AB?
The stock symbol for Bonesupport Holding AB is "BONEX."
What Stock Exchange Does Bonesupport Holding AB Trade On?
Bonesupport Holding AB is listed and trades on the Stockholm stock exchange.
Is Bonesupport Holding AB a Good Stock to Buy?
Determining whether Bonesupport Holding AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BONEX quote. (ISIN: SE0009858152)
What Is the Bonesupport Holding AB Stock Price Today?
The Bonesupport Holding AB stock price today is 187.50.
What Is the Stock Symbol for Bonesupport Holding AB?
The stock symbol for Bonesupport Holding AB is "BONEX."
What Stock Exchange Does Bonesupport Holding AB Trade On?
Bonesupport Holding AB is listed and trades on the Stockholm stock exchange.
Is Bonesupport Holding AB a Good Stock to Buy?
Determining whether Bonesupport Holding AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BONEX quote. (ISIN: SE0009858152)
Currency in SEK
187.50
+1.20(+0.64%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
179.30
188.70
52 wk Range
165.00
346.40
BONEX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
179.30188.70
52 wk Range
165.00346.40
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BONEX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
366.60
Upside
+95.52%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also offers CERAMENT Bead Tray, an adjunctive local delivery option for surgeons for targeted delivery to osseous defects and for dead space management. In addition, the company develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, and foot and ankle surgery. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.
Bonesupport Holding AB Earnings Call Summary for Q2/2025
- Net sales up 29% YoY (40% in constant currency) to SEK 284M; CERAMENT G U.S. sales surge 84%, totaling SEK 1B since launch
- Operating result (ex-incentives) SEK 62M; reported EBIT SEK 55M; operating cash flow SEK 50M; gross margin 95% in Europe/RoW
- Forecasts sales growth above 40% in constant currency for full year; CERAMENT BVF Spine launch planned for December 2025
- Exploring joint infection prevention market; considering price increases; awaiting FDA approval for CERAMENT V launch in H1 2026
- Strong financial health: 92.59% gross profit margin, 44.52% revenue growth (LTM), 4.34 current ratio, 0.02 debt-to-equity ratio
Last Updated: 2025-10-14, 11:54 a/m
Read Full TranscriptCompare BONEX to Peers and Sector
Metrics to compare | BONEX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBONEXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 87.6x | −2.5x | −0.4x | |
PEG Ratio | −1.31 | −0.07 | 0.00 | |
Price/Book | 14.4x | 1.4x | 2.6x | |
Price / LTM Sales | 10.6x | 1.7x | 3.1x | |
Upside (Analyst Target) | 100.1% | 118.1% | 58.8% | |
Fair Value Upside | Unlock | 35.5% | 9.2% | Unlock |
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 366.60
(+95.52% Upside)
Earnings
Latest Release
Feb 24, 2026
EPS / Forecast
0.67 / 0.89
Revenue / Forecast
313M / 320.16M
People Also Watch
FAQ
What Is the Bonesupport (BONEX) Stock Price Today?
The Bonesupport stock price today is 187.50 SEK.
What Stock Exchange Does Bonesupport Trade On?
Bonesupport is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for Bonesupport?
The stock symbol for Bonesupport is "BONEX."
What Is the Bonesupport Market Cap?
As of today, Bonesupport market cap is 12.57B SEK.
What Is Bonesupport's Earnings Per Share (TTM)?
The Bonesupport EPS (TTM) is 0.66.
When Is the Next Bonesupport Earnings Date?
Bonesupport will release its next earnings report on Apr 22, 2026.
From a Technical Analysis Perspective, Is BONEX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Bonesupport Stock Split?
Bonesupport has split 0 times.
How Many Employees Does Bonesupport Have?
Bonesupport has 148 employees.
What is the current trading status of Bonesupport (BONEX)?
As of Mar 31, 2026, Bonesupport (BONEX) is trading at a price of 187.50 SEK, with a previous close of 187.50 SEK. The stock has fluctuated within a day range of 179.30 SEK to 188.70 SEK, while its 52-week range spans from 165.00 SEK to 346.40 SEK.
What Is Bonesupport (BONEX) Price Target According to Analysts?
The average 12-month price target for Bonesupport is 366.60 SEK, with a high estimate of 428 SEK and a low estimate of 310 SEK. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +95.52% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.